PDF FormatRequires Adobe Acrobat Reader

Data Tables

Back back Data Tables Index Data Tables index

Sections I - VIII
I.Summary Tables
II.Deceased and Living Donor Characteristics
III.Deceased Donor Organ Recovery and Disposition
IV.Organ Procurement Organization Tables
V.Kidney Tables
VI.Pancreas Transplant Alone (PTA) Tables
VII.Pancreas After Kidney (PA k) Tables
VIII.Kidney-Pancreas Tables
Sections IX - XV
IX.Liver Tables
X.Intestine Tables
XI.Heart Tables
XII.Lung Tables
XIII.Heart-Lung Tables
XIV.Donor and Recipient Tumor Tables
XV.Supplementary Tables
 Technical Notes and Analytic Methods
 All Data Tables (373 K)



View HTMLView PDF

Section I

1.1U.S. Organ Donors by Organ and Donor Type, 1999 to 2008Table 1.1 (27 k)
1.2Number of Organs Recovered from Deceased Donors, 1999 to 2008Table 1.2 (24 k)
1.3Waiting List at End of Year, 1999 to 2008Table 1.3 (27 k)
1.4Characteristics of Waiting List Patients at End of Year, 1999 to 2008Table 1.4 (38 k)
Age
Blood Type
Residency
Gender
Previous Transplant Any Organ
Race
Patient Status
1.5Time to Transplant New Waiting List Registrations, 1999 to 2008Table 1.5 (41 k)
1.6Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk Waiting List, 1999 to 2008Table 1.6 (29 k)
1.7Transplants by Organ and Donor Type, 1999 to 2008Table 1.7 (32 k)
1.8Multi-Organ Transplants, 1999 to 2008Table 1.8 (25 k)
1.9aImmunosuppression Use by Organ in 2007 and 2008Table 1.9a (38 k)
1.9bImmunosuppression Use by Organ Maintenance Regimen at Discharge, 2008 TransplantsTable 1.9b (30 k)
1.9cImmunosuppression Use by Organ Maintenance Regimen at One Year Following Transplantation 2007 TransplantsTable 1.9c (30 k)
1.10Transplant Recipient Characteristics, 1999 to 2008Table 1.10 (37 k)
Blood Type
Residency
Gender
Race
Age
Previous Transplant Any Organ
Payment Source
1.11aOne Year Adjusted Graft Survival by Organ and Year of Transplant, 1998 to 2007Table 1.11a (30 k)
1.11bOne Year Unadjusted Graft Survival by Organ and Year of Transplant, 1998 to 2007Table 1.11b (30 k)
1.12aOne Year Adjusted Patient Survival by Organ and Year of Transplant, 1998 to 2007Table 1.12a (30 k)
1.12bOne Year Unadjusted Patient Survival by Organ and Year of Transplant, 1998 to 2007Table 1.12b (30 k)
1.13Unadjusted Graft and Patient Survival at 3 Months, 1 Year, 3 Years, 5 Years, and 10 Years Standard Errors of the Survival RatesTable 1.13 (37 k)
Standard Errors of the Survival Rates
Survival (%)
Number of Transplants For This Survival Analysis
1.14Prevalence of People Living with a Functioning Transplant at End of Year 1999 to 2007Table 1.14 (20 k)

Section II

2.1Deceased Donor Characteristics, 1999 to 2008 Deceased Donors of Any OrganTable 2.1 (46 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.2Deceased Donor Characteristics, 1999 to 2008 Kidney DonorsTable 2.2 (48 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Race
Donor Category(ECD, SCD, DCD)
2.3Deceased Donor Characteristics, 1999 to 2008 Pancreas DonorsTable 2.3 (46 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.4Deceased Donor Characteristics, 1999 to 2008 Liver DonorsTable 2.4 (46 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.5Deceased Donor Characteristics, 1999 to 2008 Intestine DonorsTable 2.5 (45 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.6Deceased Donor Characteristics, 1999 to 2008 Heart DonorsTable 2.6 (45 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Race
2.7Deceased Donor Characteristics, 1999 to 2008 Lung DonorsTable 2.7 (46 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.8Living Donor Characteristics, 1999 to 2008 Living Donors of Any OrganTable 2.8 (40 k)
Age
Blood Type
Gender
Donor Hospitalization
Race
Donor Relation
Donor Status
2.9Living Donor Characteristics, 1999 to 2008 Kidney DonorsTable 2.9 (40 k)
Age
Blood Type
Gender
Donor Hospitalization
Race
Donor Relation
Donor Status
2.10Living Donor Characteristics, 1999 to 2008 Liver Segment DonorsTable 2.10 (39 k)
Age
Blood Type
Gender
Donor Hospitalization
Race
Donor Relation
Donor Status
2.11Living Donor Characteristics, 1999 to 2008 Lung Lobe DonorsTable 2.11 (38 k)
Age
Blood Type
Gender
Donor Hospitalization
Race
Donor Relation
Donor Status
2.12Deceased Donor Organ Utilization, 1999 to 2008, Any OrganTable 2.12 (35 k)
2.13Deceased Donor Organ Utilization, 1999 to 2008, KidneyTable 2.13 (42 k)
2.14Deceased Donor Organ Utilization, 1999 to 2008, PancreasTable 2.14 (41 k)
2.15Deceased Donor Organ Utilization, 1999 to 2008, LiverTable 2.15 (44 k)
2.16Deceased Donor Organ Utilization, 1999 to 2008, IntestineTable 2.16 (37 k)
2.17Deceased Donor Organ Utilization, 1999 to 2008, HeartTable 2.17 (39 k)
2.18Deceased Donor Organ Utilization, 1999 to 2008, LungTable 2.18 (40 k)

Section III

3.1Disposition of Organs Recovered from Deceased Donors, 1999 to 2008 KidneyTable 3.1 (26 k)
3.2Reasons for Non-Use of Recovered Organs, 1999 to 2008 KidneyTable 3.2 (29 k)
3.3Reasons for Non-Recovery of Consented Organs, 1999 to 2008 KidneyTable 3.3 (28 k)
3.4Disposition of Organs Recovered from Deceased Donors, 1999 to 2008 PancreasTable 3.4 (25 k)
3.5Reasons for Non-Use of Recovered Organs, 1999 to 2008 PancreasTable 3.5 (29 k)
3.6Reasons for Non-Recovery of Consented Organs, 1999 to 2008 PancreasTable 3.6 (28 k)
3.7Disposition of Organs Recovered from Deceased Donors, 1999 to 2008 LiverTable 3.7 (27 k)
3.8Reasons for Non-Use of Recovered Organs, 1999 to 2008 LiverTable 3.8 (29 k)
3.9Reasons for Non-Recovery of Consented Organs, 1999 to 2008 LiverTable 3.9 (28 k)
3.10Disposition of Organs Recovered from Deceased Donors, 1999 to 2008 IntestineTable 3.10 (26 k)
3.11Reasons for Non-Use of Recovered Organs, 1999 to 2008 IntestineTable 3.11 (33 k)
3.12Reasons for Non-Recovery of Consented Organs, 1999 to 2008 IntestineTable 3.12 (28 k)
3.13Disposition of Organs Recovered from Deceased Donors, 1999 to 2008 HeartTable 3.13 (26 k)
3.14Reasons for Non-Use of Recovered Organs, 1999 to 2008 HeartTable 3.14 (29 k)
3.15Reasons for Non-Recovery of Consented Organs, 1999 to 2008 HeartTable 3.15 (28 k)
3.16Disposition of Organs Recovered from Deceased Donors, 1999 to 2008 LungTable 3.16 (26 k)
3.17Reasons for Non-Use of Recovered Organs, 1999 to 2008 LungTable 3.17 (29 k)
3.18Reasons for Non-Recovery of Consented Organs, 1999 to 2008 LungTable 3.18 (28 k)

Section IV

4.1Deceased Donors Procured by U.S. Organ Procurement Organizations 1999 to 2008Table 4.1 (50 k)
4.2Eligible Deaths Reported by U.S. Organ Procurement Organizations 2001 to 2008Table 4.2 (49 k)
4.3Transplant Centers Within Each OPO CMS-Designated Service Area As of May 2009, By Home State of OPOTable 4.3 (75 k)

Section V

5.1aWaiting List Patient Characteristics at End of Year Kidney Waiting List Active Waitlist Patients, 1999 to 2008Table 5.1a (46 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
PRA
Previous Transplant Same Organ
Time on Waiting List
5.1bWaiting List Patient Characteristics at End of Year Kidney Waiting List Inactive Waitlist Patients, 1999 to 2008Table 5.1b (46 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
PRA
Previous Transplant Same Organ
Time on Waiting List
5.2Time to Transplant, 1999 to 2008 New Kidney Waiting List RegistrationsTable 5.2 (158 k)
Blood Type
Age
Gender
All Patient Types
PRA
Gender and PRA
Race and PRA
Previous Transplant Any Organ
Previous Transplant and Gender
Previous Transplant and PRA
Previous Transplant and Race
Race
Residency
State of Center
5.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Kidney Waiting ListTable 5.3 (83 k)
Age
Blood Type
Diagnosis
Gender
Race
State of Center
5.4Transplant Recipient Characteristics, 1999 to 2008 Recipients of Deceased Donor KidneysTable 5.4 (30 k)
5.4aTransplant Recipient Characteristics, 1999 to 2008 Recipients of Deceased Donor non-ECD KidneysTable 5.4a (67 k)
Age
Blood Type
Residency
Gender
PRA
Race
Diagnosis
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
5.4bTransplant Recipient Characteristics, 1999 to 2008 Recipients of Deceased Donor Expanded Criteria Donors (ECD) KidneysTable 5.4b (67 k)
Age
Blood Type
Residency
Gender
PRA
Race
Diagnosis
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
5.4cTransplant Recipient Characteristics, 1999 to 2008 Recipients of Deceased Donor KidneysTable 5.4c (67 k)
Age
Blood Type
Residency
Gender
PRA
Race
Diagnosis
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
5.4dTransplant Recipient Characteristics, 1999 to 2008 Recipients of Living Donor KidneysTable 5.4d (66 k)
Age
Blood Type
Residency
Gender
PRA
Race
Donor Relation
Diagnosis
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
5.5Incidence of Transplant, 1999 to 2008 Kidney Transplants per 1 Million PopulationTable 5.5 (53 k)
5.6aImmunosuppression Use for Induction, 1999 to 2008 Recipients with Kidney TransplantsTable 5.6a (32 k)
5.6bImmunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Kidney TransplantsTable 5.6b (32 k)
5.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Kidney TransplantsTable 5.6c (30 k)
5.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Kidney TransplantsTable 5.6d (29 k)
5.6eImmunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Kidney TransplantsTable 5.6e (33 k)
5.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Kidney TransplantsTable 5.6f (30 k)
5.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Kidney TransplantsTable 5.6g (33 k)
5.6hPersistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Kidney TransplantsTable 5.6h (48 k)
5.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Kidney TransplantsTable 5.6i (32 k)
5.7aPatients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Deceased Donor non-ECD Kidney TransplantationTable 5.7a (156 k)
Blood Type
Residency
Gender
PRA
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
Diagnosis
State of Center
5.7bPatients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Deceased Donor ECD Kidney TransplantationTable 5.7b (142 k)
Blood Type
Residency
Gender
PRA
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
Diagnosis
State of Center
5.7cPatients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Deceased Donor Kidney TransplantationTable 5.7c (172 k)
Blood Type
Residency
Gender
PRA
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
Diagnosis
State of Center
5.7dPatients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Living Donor Kidney TransplantationTable 5.7d (129 k)
Blood Type
Residency
Gender
PRA
Race
Donor Age
Previous Transplant
Age
Hospitalized at Tx
Level of HLA Mismatch
Diagnosis
State of Center
5.8aAdjusted Graft Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.8a (50 k)
Age
Gender
Race
Diagnosis
State of Center
5.8bAdjusted Graft Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.8b (49 k)
Age
Gender
Race
Diagnosis
State of Center
5.8cAdjusted Graft Survival, Deceased Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.8c (49 k)
Age
Gender
Race
Diagnosis
State of Center
5.8dAdjusted Graft Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.8d (48 k)
Age
Gender
Race
Diagnosis
State of Center
5.9aAdjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney TransplantsTable 5.9a (22 k)
5.9bAdjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney TransplantsTable 5.9b (22 k)
5.9cAdjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Kidney TransplantsTable 5.9c (22 k)
5.9dAdjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants Table 5.9d (22 k)
5.10aUnadjusted Graft Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.10a (64 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.10bUnadjusted Graft Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.10b (60 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.10cUnadjusted Graft Survival, Deceased Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.10c (64 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.10dUnadjusted Graft Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.10d (66 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Relation
Donor Age
Previous Transplant Same Organ
Diagnosis
Dialysis Within 1 Week of Tx
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.11aUnadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney TransplantsTable 5.11a (22 k)
5.11bUnadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney TransplantsTable 5.11b (22 k)
5.11cUnadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Kidney TransplantsTable 5.11c (22 k)
5.11dUnadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney TransplantsTable 5.11d (22 k)
5.12aAdjusted Patient Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.12a (50 k)
Age
Gender
Race
Diagnosis
State of Center
5.12bAdjusted Patient Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.12b (49 k)
Age
Gender
Race
Diagnosis
State of Center
5.12cAdjusted Patient Survival, Deceased Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.12c (50 k)
Age
Gender
Race
Diagnosis
State of Center
5.12dAdjusted Patient Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.12d (48 k)
Age
Gender
Race
Diagnosis
State of Center
5.13aAdjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney TransplantsTable 5.13a (22 k)
5.13bAdjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney TransplantsTable 5.13b (22 k)
5.13cAdjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Kidney TransplantsTable 5.13c (22 k)
5.13dAdjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants Table 5.13d (22 k)
5.14aUnadjusted Patient Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.14a (63 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.14bUnadjusted Patient Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.14b (60 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.14cUnadjusted Patient Survival, Deceased Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.14c (64 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.14dUnadjusted Patient Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 5.14d (65 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Relation
Donor Age
Diagnosis
Dialysis Within 1 Week of Tx
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.15aUnadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney TransplantsTable 5.15a (22 k)
5.15bUnadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney TransplantsTable 5.15b (22 k)
5.15cUnadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Kidney TransplantsTable 5.15c (22 k)
5.15dUnadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants Table 5.15d (22 k)
5.16Prevalence of People Living with a Functioning Transplant at End of Year Kidney Recipients, 1999 to 2007Table 5.16 (58 k)
Blood Type
Residency
Gender
PRA
Race
Donor Type
Age
Diagnosis
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
5.17Transplants by State and Transplant Center, 1999 to 2008 KidneyTable 5.17 (98 k)

Section VI

6.1aWaiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active Waitlist Patients, 1999 to 2008Table 6.1a (39 k)
Age
Blood Type
Residency
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
6.1bWaiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Inactive Waitlist Patients, 1999 to 2008Table 6.1b (39 k)
Age
Blood Type
Residency
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
6.2Time to Transplant, 1999 to 2008 New Pancreas Transplant Alone (PTA) Waiting List RegistrationsTable 6.2 (93 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
State of Center
6.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Pancreas Transplant Alone (PTA) Waiting ListTable 6.3 (65 k)
Age
Blood Type
Gender
Race
State of Center
6.4Transplant Recipient Characteristics, 1999 to 2008 Pancreas Transplant Alone (PTA) RecipientsTable 6.4 (41 k)
Age
Blood Type
Residency
Gender
Race
Cold Ischemic Time
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
6.5Incidence of Transplant, 1999 to 2008 Pancreas Transplant Alone (PTA) Transplants per 1 Million PopulationTable 6.5 (47 k)
6.6aImmunosuppression Use for Induction, 1999 to 2008 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6a (32 k)
6.6bImmunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6b (32 k)
6.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6c (29 k)
6.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6d (29 k)
6.6eImmunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6e (29 k)
6.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6f (30 k)
6.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6g (30 k)
6.6hPersistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6h (46 k)
6.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6i (30 k)
6.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Pancreas Transplant Alone (PTA) TransplantationTable 6.7 (99 k)
Blood Type
Residency
Gender
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
6.8Adjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 6.8 (37 k)
Age
Gender
Race
State of Center
6.9Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.9 (22 k)
6.10Unadjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 6.10 (48 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
6.11Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.11 (22 k)
6.12Adjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 6.12 (37 k)
Age
Gender
Race
State of Center
6.13Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.13 (22 k)
6.14Unadjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 6.14 (47 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
6.15Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.15 (22 k)
6.16Prevalence of People Living with a Functioning Transplant at End of Year Pancreas Transplant Alone (PTA) Recipients, 1999 to 2007Table 6.16 (38 k)
Blood Type
Residency
Gender
Race
Age
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
6.17Transplants by State and Transplant Center, 1999 to 2008 Pancreas Transplant Alone (PTA)Table 6.17 (64 k)

Section VII

7.1aWaiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Active Waitlist Patients, 1999 to 2008Table 7.1a (39 k)
Age
Blood Type
Residency
Gender
Race
Previous Transplant Same Organ
Time on Waiting List
7.1bWaiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Inactive Waitlist Patients, 1999 to 2008Table 7.1b (39 k)
Age
Blood Type
Residency
Gender
Race
Previous Transplant Same Organ
Time on Waiting List
7.2Time to Transplant, 1999 to 2008 New Pancreas After Kidney (PAK) Waiting List RegistrationsTable 7.2 (93 k)
Blood Type
Age
Gender
All Patient Types
Race
Residency
State of Center
7.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Pancreas After Kidney (PAK) Waiting ListTable 7.3 (70 k)
Age
Blood Type
Gender
Race
State of Center
7.4Transplant Recipient Characteristics, 1999 to 2008 Pancreas After Kidney (PAK) RecipientsTable 7.4 (41 k)
Age
Blood Type
Residency
Gender
Race
Cold Ischemic Time
Hospitalized at Tx
Previous Transplant Same Organ
Payment Source
7.5Incidence of Transplant, 1999 to 2008 Pancreas After Kidney (PAK) Transplants per 1 Million PopulationTable 7.5 (48 k)
7.6aImmunosuppression Use for Induction, 1999 to 2008 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6a (32 k)
7.6bImmunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6b (32 k)
7.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6c (29 k)
7.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6d (29 k)
7.6eImmunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6e (30 k)
7.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6f (30 k)
7.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6g (33 k)
7.6hPersistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6h (48 k)
7.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas After Kidney (PAK) TransplantsTable 7.6i (32 k)
7.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Pancreas After Kidney (PAK) TransplantationTable 7.7 (106 k)
Blood Type
Residency
Gender
Race
Donor Age
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
7.8Adjusted Graft Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 7.8 (42 k)
Age
Gender
Race
State of Center
7.9Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) TransplantsTable 7.9 (22 k)
7.10Unadjusted Graft Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 7.10 (52 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
7.11Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) TransplantsTable 7.11 (22 k)
7.12Adjusted Patient Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 7.12 (42 k)
Age
Gender
Race
State of Center
7.13Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) TransplantsTable 7.13 (22 k)
7.14Unadjusted Patient Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 7.14 (51 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
7.15Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) TransplantsTable 7.15 (22 k)
7.16Prevalence of People Living with a Functioning Transplant at End of Year Pancreas After Kidney (PAK) Recipients, 1999 to 2007Table 7.16 (37 k)
Blood Type
Residency
Gender
Race
Age
Hospitalized at Tx
Previous Transplant Same Organ
7.17Transplants by State and Transplant Center, 1999 to 2008 Pancreas After Kidney (PAK)Table 7.17 (79 k)

Section VIII

8.1aWaiting List Patient Characteristics at End of Year Kidney-Pancreas Waiting List Active Waitlist Patients, 1999 to 2008Table 8.1a (39 k)
Age
Blood Type
Residency
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
8.1bWaiting List Patient Characteristics at End of Year Kidney-Pancreas Waiting List Inactive Waitlist Patients, 1999 to 2008Table 8.1b (39 k)
Age
Blood Type
Residency
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
8.2Time to Transplant, 1999 to 2008 New Kidney-Pancreas Waiting List RegistrationsTable 8.2 (110 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
State of Center
8.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Kidney-Pancreas Waiting ListTable 8.3 (70 k)
Age
Blood Type
Gender
Race
State of Center
8.4Transplant Recipient Characteristics, 1999 to 2008 Kidney-Pancreas RecipientsTable 8.4 (58 k)
Age
Blood Type
Residency
Gender
Race
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
8.5Incidence of Transplant, 1999 to 2008 Kidney-Pancreas Transplants per 1 Million PopulationTable 8.5 (48 k)
8.6aImmunosuppression Use for Induction, 1999 to 2008 Recipients with Kidney-Pancreas TransplantsTable 8.6a (32 k)
8.6bImmunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Kidney-Pancreas TransplantsTable 8.6b (32 k)
8.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Kidney-Pancreas TransplantsTable 8.6c (29 k)
8.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Kidney-Pancreas TransplantsTable 8.6d (29 k)
8.6eImmunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Kidney-Pancreas TransplantsTable 8.6e (30 k)
8.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Kidney-Pancreas TransplantsTable 8.6f (30 k)
8.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Kidney-Pancreas TransplantsTable 8.6g (33 k)
8.6hPersistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Kidney-Pancreas TransplantsTable 8.6h (37 k)
8.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Kidney-Pancreas TransplantsTable 8.6i (31 k)
8.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Kidney-Pancreas TransplantationTable 8.7 (125 k)
Blood Type
Residency
Gender
PRA
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
Previous Kidney Transplant
Previous Pancreas Transplant
State of Center
8.8Adjusted Graft Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 8.8 (55 k)
Kidney Graft - by Age
Pancreas Graft - by Age
Kidney Graft - by Gender
Pancreas Graft - by Gender
Kidney Graft - by Race
Pancreas Graft - by Race
Kidney Graft - by State of Center
Pancreas Graft - by State of Center
8.9aAdjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Kidney GraftTable 8.9a (22 k)
8.9bAdjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Pancreas GraftTable 8.9b (22 k)
8.10Unadjusted Graft Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 8.10 (84 k)
Kidney Graft - by Age
Pancreas Graft - by Age
Kidney Graft - by Blood Type
Pancreas Graft - by Blood Type
Kidney Graft - by Residency
Pancreas Graft - by Residency
Kidney Graft - by Gender
Pancreas Graft - by Gender
Kidney Graft - by PRA
Pancreas Graft - by PRA
Kidney Graft - by Race
Pancreas Graft - by Race
Kidney Graft - by Center Volume
Pancreas Graft - by Center Volume
Kidney Graft - by Donor Age
Pancreas Graft - by Donor Age
Previous Transplant Same Organ Kidney Graft
Previous Transplant Same Organ Pancreas Graft
Kidney Graft - by Cold Ischemic Time
Kidney Graft - by Hospitalized at Tx
Pancreas Graft - by Hospitalized at Tx
Kidney Graft - by Level of HLA Mismatch
Pancreas Graft - by Level of HLA Mismatch
Kidney Graft - by Previous Kidney Transplant
Pancreas Graft - by Previous Kidney Transplant
Kidney Graft - by Previous Pancreas Transplant
Pancreas Graft - by Previous Pancreas Transplant
Kidney Graft - by State of Center
Pancreas Graft - by State of Center
8.11aUnadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Kidney GraftTable 8.11a (22 k)
8.11bUnadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Pancreas GraftTable 8.11b (22 k)
8.12Adjusted Patient Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 8.12 (42 k)
Age
Gender
Race
State of Center
8.13Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 YearsTable 8.13 (22 k)
8.14Unadjusted Patient Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 8.14 (56 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
8.15Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 YearsTable 8.15 (22 k)
8.16Prevalence of People Living with a Functioning Transplant at End of Year Kidney-Pancreas Recipients, 1999 to 2007Table 8.16 (46 k)
Blood Type
Residency
Gender
Race
Age
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
8.17Transplants by State and Transplant Center, 1999 to 2008 Kidney-PancreasTable 8.17 (71 k)

Section IX

9.1aWaiting List Patient Characteristics at End of Year Liver Waiting List Active Waitlist Patients, 1999 to 2008Table 9.1a (53 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Patient Status
Previous Transplant Same Organ
Time on Waiting List
9.1bWaiting List Patient Characteristics at End of Year Liver Waiting List Inactive Waitlist Patients, 1999 to 2008Table 9.1b (44 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
9.2aEvents 7 & 15 Days After Listing 2007 and 2008 Liver Registrations with Initial Status 1Table 9.2a (21 k)
9.2bEvents 30 Days After Snapshot of Prevalent Waiting List Adult Patients on Liver Waiting List on Jan. 1, 2008Table 9.2b (38 k)
30 Days After Snapshot
60 Days After Snapshot
90 Days After Snapshot
9.2cEvents 30 Days After Snapshot of Prevalent Waiting List Pediatric Patients on Liver Waiting List on Jan. 1, 2008Table 9.2c (36 k)
30 Days After Snapshot
60 Days After Snapshot
90 Days After Snapshot
9.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Liver Waiting ListTable 9.3 (88 k)
Age
Blood Type
Diagnosis
Gender
Race
Patient Status
State of Center
9.4aTransplant Recipient Characteristics, 1999 to 2008 Recipients of Deceased Donor LiversTable 9.4a (53 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
Procedure Type
9.4bTransplant Recipient Characteristics, 1999 to 2008 Recipients of Living Donor LiversTable 9.4b (52 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Donor Relation
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
9.5Incidence of Transplant, 1999 to 2008 Liver Transplants per 1 Million PopulationTable 9.5 (48 k)
9.6aImmunosuppression Use for Induction, 1999 to 2008 Recipients with Liver TransplantsTable 9.6a (32 k)
9.6bImmunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Liver TransplantsTable 9.6b (32 k)
9.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Liver TransplantsTable 9.6c (29 k)
9.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Liver TransplantsTable 9.6d (29 k)
9.6eImmunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Liver TransplantsTable 9.6e (33 k)
9.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Liver TransplantsTable 9.6f (30 k)
9.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Liver TransplantsTable 9.6g (33 k)
9.6hPersistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Liver TransplantsTable 9.6h (37 k)
9.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Liver TransplantsTable 9.6i (32 k)
9.7aPatients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Deceased Donor Liver TransplantationTable 9.7a (126 k)
Blood Type
Residency
Gender
Patient Status
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
9.7bPatients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Living Donor Liver TransplantationTable 9.7b (105 k)
Blood Type
Residency
Gender
Patient Status
Race
Donor Age
Previous Transplant
Age
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
9.8aAdjusted Graft Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.8a (49 k)
Age
Gender
Race
Diagnosis
State of Center
9.8bAdjusted Graft Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.8b (42 k)
Age
Gender
Race
Diagnosis
State of Center
9.9aAdjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver TransplantsTable 9.9a (22 k)
9.9bAdjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver TransplantsTable 9.9b (22 k)
9.10aUnadjusted Graft Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.10a (60 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
9.10bUnadjusted Graft Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.10b (54 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Relation
Donor Age
Previous Transplant Same Organ
Diagnosis
On Life Support at Tx
Hospitalized at Tx
State of Center
9.11aUnadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver TransplantsTable 9.11a (22 k)
9.11bUnadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver TransplantsTable 9.11b (22 k)
9.12aAdjusted Patient Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.12a (49 k)
Age
Gender
Race
Diagnosis
State of Center
9.12bAdjusted Patient Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.12b (42 k)
Age
Gender
Race
Diagnosis
State of Center
9.13aAdjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver TransplantsTable 9.13a (22 k)
9.13bAdjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver TransplantsTable 9.13b (22 k)
9.14aUnadjusted Patient Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.14a (60 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Age
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
9.14bUnadjusted Patient Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 9.14b (54 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Relation
Donor Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
State of Center
9.15aUnadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver TransplantsTable 9.15a (22 k)
9.15bUnadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver TransplantsTable 9.15b (22 k)
9.16Prevalence of People Living with a Functioning Transplant at End of Year Liver Recipients, 1999 to 2007Table 9.16 (54 k)
Blood Type
Residency
Gender
Patient Status
Race
Donor Type
Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
9.17Transplants by State and Transplant Center, 1999 to 2008 LiverTable 9.17 (70 k)

Section X

10.1aWaiting List Patient Characteristics at End of Year Intestine Waiting List Active Waitlist Patients, 1999 to 2008Table 10.1a (43 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
10.1bWaiting List Patient Characteristics at End of Year Intestine Waiting List Inactive Waitlist Patients, 1999 to 2008Table 10.1b (42 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
10.2Time to Transplant, 1999 to 2008 New Intestine Waiting List RegistrationsTable 10.2 (80 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
State of Center
10.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Intestine Waiting ListTable 10.3 (60 k)
Age
Blood Type
Diagnosis
Gender
Race
State of Center
10.4Transplant Recipient Characteristics, 1999 to 2008 Intestine RecipientsTable 10.4 (44 k)
Age
Blood Type
Residency
Gender
Race
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
10.5Incidence of Transplant, 1999 to 2008 Intestine Transplants per 1 Million PopulationTable 10.5 (47 k)
10.6aImmunosuppression Use for Induction, 1999 to 2008 Recipients with Intestine TransplantsTable 10.6a (32 k)
10.6bImmunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Intestine TransplantsTable 10.6b (30 k)
10.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Intestine TransplantsTable 10.6c (29 k)
10.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Intestine TransplantsTable 10.6d (28 k)
10.6eImmunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Intestine TransplantsTable 10.6e (29 k)
10.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Intestine TransplantsTable 10.6f (30 k)
10.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Intestine TransplantsTable 10.6g (32 k)
10.6hPersistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Intestine TransplantsTable 10.6h (28 k)
10.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Intestine TransplantsTable 10.6i (31 k)
10.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Intestine TransplantationTable 10.7 (91 k)
Blood Type
Residency
Gender
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
10.8Adjusted Graft Survival, Intestine Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 10.8 (43 k)
Age
Gender
Race
Diagnosis
State of Center
10.9Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine TransplantsTable 10.9 (22 k)
10.10Unadjusted Graft Survival, Intestine Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 10.10 (48 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
10.11Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine TransplantsTable 10.11 (21 k)
10.12Adjusted Patient Survival, Intestine Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 10.12 (41 k)
Age
Gender
Race
Diagnosis
State of Center
10.13Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine TransplantsTable 10.13 (21 k)
10.14Unadjusted Patient Survival, Intestine Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 10.14 (47 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
10.15Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine TransplantsTable 10.15 (22 k)
10.16Prevalence of People Living with a Functioning Transplant at End of Year Intestine Recipients, 1999 to 2007Table 10.16 (42 k)
Blood Type
Residency
Gender
Race
Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
10.17Transplants by State and Transplant Center, 1999 to 2008 IntestineTable 10.17 (43 k)

Section XI

11.1aWaiting List Patient Characteristics at End of Year Heart Waiting List Active Waitlist Patients, 1999 to 2008Table 11.1a (44 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Patient Status
Previous Transplant Same Organ
Time on Waiting List
11.1bWaiting List Patient Characteristics at End of Year Heart Waiting List Inactive Waitlist Patients, 1999 to 2008Table 11.1b (44 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
11.2aEvents 7 & 30 Days After Listing 2007 and 2008 Heart Registrations with Initial Status 1ATable 11.2a (19 k)
11.2bEvents 30 Days After Snapshot of Prevalent Waiting List Patients on Heart Waiting List on Jan. 1, 2008Table 11.2b (33 k)
30 Days After Snapshot
60 Days After Snapshot
90 Days After Snapshot
11.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Heart Waiting ListTable 11.3 (75 k)
Age
Blood Type
Diagnosis
Gender
Race
Patient Status
State of Center
11.4Transplant Recipient Characteristics, 1999 to 2008 Heart RecipientsTable 11.4 (49 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
Procedure Type
11.5Incidence of Transplant, 1999 to 2008 Heart Transplants per 1 Million PopulationTable 11.5 (48 k)
11.6aImmunosuppression Use for Induction, 1999 to 2008 Recipients with Heart TransplantsTable 11.6a (32 k)
11.6bImmunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Heart TransplantsTable 11.6b (32 k)
11.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Heart TransplantsTable 11.6c (29 k)
11.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Heart TransplantsTable 11.6d (29 k)
11.6eImmunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Heart TransplantsTable 11.6e (32 k)
11.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Heart TransplantsTable 11.6f (31 k)
11.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Heart TransplantsTable 11.6g (33 k)
11.6hPersistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Heart TransplantsTable 11.6h (35 k)
11.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Heart TransplantsTable 11.6i (33 k)
11.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Heart TransplantationTable 11.7 (119 k)
Blood Type
Residency
Gender
Patient Status
Race
Donor Age
Previous Transplant
Procedure Type
Age
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
11.8Adjusted Graft Survival, Heart Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 11.8 (48 k)
Age
Gender
Race
Diagnosis
State of Center
11.9Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart TransplantsTable 11.9 (21 k)
11.10Unadjusted Graft Survival, Heart Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 11.10 (57 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Procedure Type
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
11.11Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart TransplantsTable 11.11 (21 k)
11.12Adjusted Patient Survival, Heart Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 11.12 (46 k)
Age
Gender
Race
Diagnosis
State of Center
11.13Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart TransplantsTable 11.13 (21 k)
11.14Unadjusted Patient Survival, Heart Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 11.14 (57 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Age
Procedure Type
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
11.15Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart TransplantsTable 11.15 (21 k)
11.16Prevalence of People Living with a Functioning Transplant at End of Year Heart Recipients, 1999 to 2007Table 11.16 (45 k)
Blood Type
Residency
Gender
Patient Status
Race
Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Procedure Type
11.17Transplants by State and Transplant Center, 1999 to 2008 HeartTable 11.17 (71 k)

Section XII

12.1aWaiting List Patient Characteristics at End of Year Lung Waiting List Active Waitlist Patients, 1999 to 2008Table 12.1a (51 k)
Age
Blood Type
Residency
Diagnosis
Gender
Lung Allocation Score
Previous Transplant Any Organ
Race
Lung Diagnosis Group
Previous Transplant Same Organ
Time on Waiting List
12.1bWaiting List Patient Characteristics at End of Year Lung Waiting List Inactive Waitlist Patients, 1999 to 2008Table 12.1b (56 k)
Age
Blood Type
Residency
Diagnosis
Gender
Lung Allocation Score
Previous Transplant Any Organ
Race
Lung Diagnosis Group
Previous Transplant Same Organ
Time on Waiting List
12.2Time to Transplant, 1999 to 2008 New Lung Waiting List RegistrationsTable 12.2 (87 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
State of Center
12.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Lung Waiting ListTable 12.3 (81 k)
Age
Blood Type
Diagnosis
Gender
Lung Allocation Score
Race
Lung Diagnosis Group
State of Center
12.4Transplant Recipient Characteristics, 1999 to 2008 Recipients of Deceased Donor LungsTable 12.4 (55 k)
Age
Blood Type
Residency
Gender
Race
Lung Diagnosis Group
Diagnosis
Cold Ischemic Time
Lung Allocation Score
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
Procedure Type
12.5Incidence of Transplant, 1999 to 2008 Lung Transplants per 1 Million PopulationTable 12.5 (47 k)
12.6aImmunosuppression Use for Induction, 1999 to 2008 Recipients with Lung TransplantsTable 12.6a (32 k)
12.6bImmunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Lung TransplantsTable 12.6b (32 k)
12.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Lung TransplantsTable 12.6c (29 k)
12.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Lung TransplantsTable 12.6d (29 k)
12.6eImmunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Lung TransplantsTable 12.6e (32 k)
12.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Lung TransplantsTable 12.6f (30 k)
12.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Lung TransplantsTable 12.6g (32 k)
12.6hPersistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Lung TransplantsTable 12.6h (46 k)
12.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Lung TransplantsTable 12.6i (33 k)
12.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Deceased Donor Lung TransplantationTable 12.7 (126 k)
Blood Type
Residency
Gender
Race
Donor Age
Lung Diagnosis Group
Previous Transplant
Procedure Type
Age
Cold Ischemic Time
Lung Allocation Score
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
12.8Adjusted Graft Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 12.8 (44 k)
Age
Gender
Race
Lung Diagnosis Group
Diagnosis
Lung Allocation Score
State of Center
12.9Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 YearsTable 12.9 (22 k)
12.10Unadjusted Graft Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 12.10 (54 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Lung Diagnosis Group
Previous Transplant Same Organ
Procedure Type
Diagnosis
Cold Ischemic Time
Lung Allocation Score
On Life Support at Tx
Hospitalized at Tx
State of Center
12.11Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 YearsTable 12.11 (22 k)
12.12Adjusted Patient Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 12.12 (44 k)
Age
Gender
Race
Lung Diagnosis Group
Diagnosis
Lung Allocation Score
State of Center
12.13Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 YearsTable 12.13 (22 k)
12.14Unadjusted Patient Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 12.14 (54 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Lung Diagnosis Group
Procedure Type
Diagnosis
Cold Ischemic Time
Lung Allocation Score
On Life Support at Tx
Hospitalized at Tx
State of Center
12.15Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 YearsTable 12.15 (22 k)
12.16Prevalence of People Living with a Functioning Transplant at End of Year Lung Recipients, 1999 to 2007Table 12.16 (49 k)
Blood Type
Residency
Gender
Race
Donor Type
Lung Diagnosis Group
Age
Diagnosis
Lung Allocation Score
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Procedure Type
12.17Transplants by State and Transplant Center, 1999 to 2008 LungTable 12.17 (55 k)

Section XIII

13.1aWaiting List Patient Characteristics at End of Year Heart-Lung Waiting List Active Waitlist Patients, 1999 to 2008Table 13.1a (48 k)
Age
Blood Type
Residency
Diagnosis
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
13.1bWaiting List Patient Characteristics at End of Year Heart-Lung Waiting List Inactive Waitlist Patients, 1999 to 2008Table 13.1b (48 k)
Age
Blood Type
Residency
Diagnosis
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
13.2Time to Transplant, 1999 to 2008 New Heart-Lung Waiting List RegistrationsTable 13.2 (78 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
State of Center
13.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Heart-Lung Waiting ListTable 13.3 (72 k)
Age
Blood Type
Diagnosis
Diagnosis
Gender
Race
State of Center
13.4Transplant Recipient Characteristics, 1999 to 2008 Heart-Lung RecipientsTable 13.4 (43 k)
Age
Blood Type
Residency
Gender
Race
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
13.5Incidence of Transplant, 1999 to 2008 Heart-Lung Transplants per 1 Million PopulationTable 13.5 (46 k)
13.6aImmunosuppression Use for Induction, 1999 to 2008 Recipients with Heart-Lung TransplantsTable 13.6a (28 k)
13.6bImmunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Heart-Lung TransplantsTable 13.6b (30 k)
13.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Heart-Lung TransplantsTable 13.6c (29 k)
13.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Heart-Lung TransplantsTable 13.6d (28 k)
13.6eImmunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Heart-Lung TransplantsTable 13.6e (30 k)
13.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Heart-Lung TransplantsTable 13.6f (30 k)
13.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Heart-Lung TransplantsTable 13.6g (32 k)
13.6hPersistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Heart-Lung TransplantsTable 13.6h (37 k)
13.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Heart-Lung TransplantsTable 13.6i (32 k)
13.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Heart-Lung TransplantationTable 13.7 (83 k)
Blood Type
Residency
Gender
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
13.8Adjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 13.8 (41 k)
Age
Gender
Race
Diagnosis
State of Center
13.9Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung TransplantsTable 13.9 (22 k)
13.10Unadjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 13.10 (47 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
13.11Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung TransplantsTable 13.11 (22 k)
13.12Adjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 13.12 (41 k)
Age
Gender
Race
Diagnosis
State of Center
13.13Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung TransplantsTable 13.13 (22 k)
13.14Unadjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 13.14 (47 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
13.15Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung TransplantsTable 13.15 (22 k)
13.16Prevalence of People Living with a Functioning Transplant at End of Year Heart-Lung Recipients, 1999 to 2007Table 13.16 (42 k)
Blood Type
Residency
Gender
Race
Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
13.17Transplants by State and Transplant Center, 1999 to 2008 Heart-LungTable 13.17 (57 k)

Section XIV

14.1History of Cancer among Deceased Donors, 1999 to 2008Table 14.1 (29 k)
14.2Recipient Recurrence of Pretransplant Malignancies, 1999 to 2008Table 14.2 (44 k)
14.3Recipient De Novo Posttransplant Solid Malignancies, 1999 to 2008 by Transplant TypeTable 14.3 (30 k)
14.4Recipient De Novo Posttransplant Lymphoproliferative Disorders (PTLD), 1999 to 2008 by Transplant TypeTable 14.4 (30 k)
14.5History of Cancer among Deceased Kidney Donors 1999 to 2008Table 14.5 (29 k)
14.6De Novo Posttransplant Solid Malignancy, 1999 to 2008 Kidney RecipientsTable 14.6 (32 k)
14.7History of Cancer among Deceased Liver Donors 1999 to 2008Table 14.7 (29 k)
14.8De Novo Posttransplant Solid Malignancy, 1999 to 2008 Liver RecipientsTable 14.8 (32 k)
14.9History of Cancer among Deceased Heart Donors 1999 to 2008Table 14.9 (29 k)
14.10De Novo Posttransplant Solid Malignancy, 1999 to 2008 Heart RecipientsTable 14.10 (32 k)

Section XV

15.1Waiting Time Before Transplant - Excluding Inactive Time, Censored at WL Removal New Waiting List Registrations, 1999 to 2008Table 15.1 (42 k)
15.2Time to Transplant, 1999 to 2008 New Liver Waiting List RegistrationsTable 15.2 (115 k)
Blood Type
Age
Gender
All Patient Types
Patient Status
Previous Transplant Any Organ
Race
Residency
State of Center
15.3Time to Transplant, 1999 to 2008 New Heart Waiting List RegistrationsTable 15.3 (103 k)
Blood Type
Age
Gender
All Patient Types
Patient Status
Previous Transplant Any Organ
Race
Residency
State of Center
15.4aSteroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Deceased Donor KidneysTable 15.4a (47 k)
Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Deceased Donor Kidneys
Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2007 Recipients of Deceased Donor Kidneys
Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2006 Recipients of Deceased Donor Kidneys
15.4bSteroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Living Donor KidneysTable 15.4b (46 k)
Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Living Donor Kidneys
Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2007 Recipients of Living Donor Kidneys
Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2006 Recipients of Living Donor Kidneys
15.5aSteroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Deceased Donor LiversTable 15.5a (46 k)
Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Deceased Donor Livers
Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2007 Recipients of Deceased Donor Livers
Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2006 Recipients of Deceased Donor Livers
15.5bSteroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Living Donor LiversTable 15.5b (45 k)
Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Living Donor Livers
Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2007 Recipients of Living Donor Livers
Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2006 Recipients of Living Donor Livers
15.6Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Heart TransplantsTable 15.6 (45 k)
Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Heart Transplants
Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2007 Recipients of Heart Transplants
Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2006 Recipients of Heart Transplants
15.7Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Kidney TransplantsTable 15.7 (31 k)
15.8Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 15.8 (30 k)
15.9Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Pancreas After Kidney (PAK) TransplantsTable 15.9 (30 k)
15.10Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Kidney-Pancreas TransplantsTable 15.10 (30 k)
15.11Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Liver TransplantsTable 15.11 (31 k)
15.12Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Intestine TransplantsTable 15.12 (30 k)
15.13Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Heart TransplantsTable 15.13 (31 k)
15.14Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Lung TransplantsTable 15.14 (31 k)
15.15Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Heart-Lung TransplantsTable 15.15 (30 k)